COVID-19 vaccines authorized in US appear to be “very protective” against variants

351781

February 23, 2021

5 min read

Source/Disclosures

Source: Press Briefing

Disclosures: Gandhi reports no relevant financial disclosures. Healio Primary Care was unable to confirm Gronvall and Pekosz’s relevant financial disclosures at the time of publication.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

ADDED TO EMAIL ALERTS

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The emergence of SARS-CoV-2 variants worldwide has led to concern and confusion among the general public.

Recently, South Africa halted its rollout of the AstraZeneca-Oxford COVID-19 vaccine after preliminary data showed the vaccine provided limited protection against the country’s dominant B.1.351 variant. This has drawn concern that COVID-19 vaccines may not protect against the emerging SARS-CoV-2 variants.

During a press briefing, Gigi Gronvall, PhD, an immunologist and associate professor in the department of environmental health and engineering at John Hopkins Bloomberg School of Public Health, said that “it’s pretty normal for viruses to mutate like this — almost all viruses do…

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close